Skip to main content
. 2014 Sep 3;32(39):4932–4937. doi: 10.1016/j.vaccine.2014.07.031

Table 1.

Titers of neutralizing antibodies (nAbs) raised in guinea pigs.

Guinea pig groups (n = 6)
1 2 3 4 5 6 7 8 9 1, 3, 7, 8 2, 4, 5, 6, 9 Control
AHSV 1 112 11
(48–176) (2–19)



AHSV 2 37 10
(27–48) (1–19)



AHSV 3 341 19
(236–447) (11–28)



AHSV 4 171 12
(118–224) (9–16)



AHSV 5 179 53
(14–345) (40–67)



AHSV 6 1365 12 117
(942–1788) (3–21) (58–177)



AHSV 7 8 122 20
(3–13) (46–197) (12–28)



AHSV 8 3 96 4 2
(1 –4) (10–87) (2–7) (0–4)



AHSV 9 24 853 19
(17–31) (642–1065) (10–27)

Single VP2 proteins (1–9) or with cocktails of 4 or 5 different VP2 proteins (1, 3, 7, 8 or 2, 4, 5, 6, 9, respectively) were used to immunize six guinea pigs per group. Titers of nAbs against each of the AHSV serotypes (AHSV-1–AHSV-9) were determined. The average nAb titers were calculated and the 95% confidence interval is indicated between brackets. Titers of nAbs <2 were evaluated as 0.